StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)

Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%

AbbVie price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

AbbVie's price to book ratio was 236.0× on Jul 31, 2025, against 41.0× a year earlier. Over the last 5 years it ranged from 8.8× to 236.0×, with a median of 18.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 2025236.0×+183.7
2024Dec 31, 202452.2×+29.5
2023Dec 29, 202322.7×+4.8
2022Dec 30, 202218.0×+0.2
2021Dec 31, 202117.8×+6.5
2020Dec 31, 202011.2×−30.4
2018Jul 31, 201841.6×+18.3
2017Dec 29, 201723.3×+7.4
2016Dec 30, 201615.8×−4.0
2015Dec 31, 201519.9×−2.8
2014Dec 31, 201422.7×−0.9
2013Dec 31, 201323.6×–

More AbbVie figures

See a number that looks wrong?